We used cetuximab to target the EGF receptor (EGFR) expressed on different colon cancer cell lines, and the EGF receptor expression profile measured by the flow cytometry was showed in Figure 2A, which suggested that among the three cell lines (HCT-116, HT-29, SW-620) we studied. This evidence concerns the gene EGFR and colonic neoplasm.